Barclays Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price objective cut by Barclays from $76.00 to $43.00 in a report released on Friday,Benzinga reports. They currently have an overweight rating on the stock.

Other equities research analysts also recently issued reports about the company. Royal Bank of Canada decreased their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday. KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $79.67.

Acadia Healthcare Stock Performance

ACHC opened at $38.23 on Friday. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The firm has a market capitalization of $3.55 billion, a P/E ratio of 12.53, a price-to-earnings-growth ratio of 1.71 and a beta of 1.33. The stock’s 50 day moving average price is $54.15 and its two-hundred day moving average price is $64.54. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year. On average, equities analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds have recently made changes to their positions in ACHC. Teachers Retirement System of The State of Kentucky increased its holdings in shares of Acadia Healthcare by 8.5% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 56,594 shares of the company’s stock worth $3,589,000 after buying an additional 4,426 shares in the last quarter. Neo Ivy Capital Management bought a new stake in Acadia Healthcare during the 3rd quarter worth approximately $758,000. Coldstream Capital Management Inc. increased its holdings in Acadia Healthcare by 7.5% during the 3rd quarter. Coldstream Capital Management Inc. now owns 6,167 shares of the company’s stock valued at $391,000 after purchasing an additional 430 shares in the last quarter. Geode Capital Management LLC raised its position in Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after purchasing an additional 14,197 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd boosted its stake in Acadia Healthcare by 40.6% in the third quarter. Y Intercept Hong Kong Ltd now owns 36,605 shares of the company’s stock worth $2,321,000 after purchasing an additional 10,572 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.